UZleuven
Leuven, 3000, Belgium
NCT Number: NCT02010983
Patient with achalasia have a 10-50 fold increased risk to develop esophageal squamous cell carcinoma (ESCC). Early diagnosis of ESCC is essential, and detection of an earlier dysplastic stage is preferred. Endoscopic detection is however difficult and often delayed. Chromoendoscopy with Lugol dye increases detection rates dysplasia and ESCC to 91-100%. The aim of this study was therefore to evaluate a screening program using chromoendoscopy with Lugol to detect dysplasia in patients with idiopathic achalasia.
A second objective is to study the relationship between foodstasis and the development op dysplasia
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Leuven, 3000, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
chromoendoscopy (lugol stain and virtual chromoendoscopy)
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
KU Leuven
Other
Screening for Dysplasia in Longstanding Idiopathic Achalasia: a Prospective Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.